Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2026

Conditions
Glioma, MalignantComputer-Assisted
Interventions
DIAGNOSTIC_TEST

Validation of IDH1 mutations from the radiomics model

During surgery, clinicians will select several typical target sites for puncture based on the preoperative model outputs. After surgery, the acquired tumour tissues will be subjected to histological diagnosis and pathological diagnosis by professional pathologists, and the results will be compared with the model output to verify its accuracy.

Trial Locations (1)

200433

Huashan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

Huashan Hospital

OTHER

collaborator

Fudan University

OTHER

lead

Mingge LLC

INDUSTRY

NCT05969691 - Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas | Biotech Hunter | Biotech Hunter